Literature DB >> 18348312

Gamma heavy chain disease in a patient with diabetes and chronic renal insufficiency: diagnostic assessment of the heavy chain fragment.

Maria Teresa Lee1, Anil Parwani, Richard Humphrey, Robert G Hamilton, Donna I Myers, Barbara Detrick.   

Abstract

Heavy chain diseases are rare B-cell disorders that are characterized by an overproduction of abnormal and structurally incomplete monoclonal immunoglobulin (Ig) heavy chains and are devoid of light chains. We describe a case of a 62 year-old African-American woman with a long history of poorly controlled type 2 diabetes and subsequent probable diabetic nephropathy, hypertension, and recent onset of peripheral neuropathy involving all extremities. Routine laboratory testing revealed a distinct beta spike by urine protein electrophoresis (UPEP). No serum abnormality was noted on serum protein electrophoresis (SPEP). Serum and urine immunofixation demonstrated an IgG heavy chain protein devoid of any corresponding light chains. IgG subclasses identified IgG1 as the predominant IgG component but when we added all the subclasses, the sum, 683.4 mg/dL, failed to come close to our total IgG of 1,770 mg/dL. Therefore, a urine IgG subclass determination was performed in-house and we identified a subclass 3 gamma chain. In conclusion, we portray a patient with an underlying monoclonal gamma heavy chain disease (HCD) who presented with a complex medical history. The evaluation of IgG subclasses in the context of a HCD may be limited by the capability of the test to recognize the particular IgG fragment. (Copyright ) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348312      PMCID: PMC6648955          DOI: 10.1002/jcla.20233

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

Review 1.  Heavy-chain diseases.

Authors:  J P Fermand; J C Brouet
Journal:  Hematol Oncol Clin North Am       Date:  1999-12       Impact factor: 3.722

2.  CLINICAL AND IMMUNOCHEMICAL STUDIES OF FOUR CASES OF HEAVY (H-GAMMA-2) CHAIN DISEASE.

Authors:  E F OSSERMAN; K TAKATSUKI
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

3.  HEAVY CHAIN DISEASE- A NEW DISORDER OF SERUM GAMMA-GLOBULINS : REPORT OF THE FIRST CASE.

Authors:  E C FRANKLIN; J LOWENSTEIN; B BIGELOW; M MELTZER
Journal:  Am J Med       Date:  1964-09       Impact factor: 4.965

Review 4.  Heavy chain deposition disease: the disease spectrum.

Authors:  N Kambham; G S Markowitz; G B Appel; M J Kleiner; P Aucouturier; V D D'agati
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

Review 5.  Human IgG subclass measurements in the clinical laboratory.

Authors:  R G Hamilton
Journal:  Clin Chem       Date:  1987-10       Impact factor: 8.327

Review 6.  Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis.

Authors:  K D Fine; M J Stone
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

7.  The amino acid sequence of a monoclonal gamma 3-heavy chain from a patient with articular gamma-heavy chain deposition disease.

Authors:  M Danevad; K Sletten; P I Gaarder; O J Mellbye; G Husby
Journal:  Scand J Immunol       Date:  2000-06       Impact factor: 3.487

8.  Gamma-heavy chain disease: review of 23 cases.

Authors:  Dietlind L Wahner-Roedler; Thomas E Witzig; Laura L Loehrer; Robert A Kyle
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

Review 9.  Heavy chain disease.

Authors:  Thomas E Witzig; Dietlind L Wahner-Roedler
Journal:  Curr Treat Options Oncol       Date:  2002-06

10.  Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia.

Authors:  Jun Soma; Kozo Sato; Tsutomu Sakuma; Hirotaka Saito; Hiroshi Sato; Toshinobu Sato; Acha Abbas; Pierre Aucouturier
Journal:  Am J Kidney Dis       Date:  2004-01       Impact factor: 8.860

  10 in total
  3 in total

1.  Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.

Authors:  Shannon Bieliauskas; Raymond R Tubbs; Chris M Bacon; Camellia Eshoa; Kathryn Foucar; Sarah E Gibson; Steven H Kroft; Aliyah R Sohani; Steven H Swerdlow; James R Cook
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

Review 2.  Heart transplantation in cardiac amyloidosis.

Authors:  Matthew Sousa; Gregory Monohan; Navin Rajagopalan; Alla Grigorian; Maya Guglin
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

3.  Gamma heavy chain disease in a patient with rheumatoid arthritis--a laboratory evaluation.

Authors:  Wibke Johannis; Jenny Blommer; Andreas R Klatt; Joerg H Renno; Klaus Wielckens
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.